Related references
Note: Only part of the references are listed.Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha-synuclein and beta-amyloid aggregates
Barbara E. Stopschinski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy
Taina M. Marques et al.
MOLECULAR NEUROBIOLOGY (2017)
Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type
Elisabet Ihse et al.
SCIENTIFIC REPORTS (2017)
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants
G. Lopez et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
microRNA-7 Protects Against 1-Methyl-4-Phenylpyridinium Iodide-Induced Cell Apoptosis in SH-SY5Y Cells by Directly Targeting Krupple-Like Factor 4
Bin Kong et al.
DNA AND CELL BIOLOGY (2016)
Cerebrospinal Fluid Biomarkers in Alzheimer's and Parkinson's Diseases-From Pathophysiology to Clinical Practice
Kaj Blennow et al.
MOVEMENT DISORDERS (2016)
Synucleinopathies: past, present and future
M. G. Spillantini et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study
Sofie Solvsten Sorensen et al.
TRANSLATIONAL NEURODEGENERATION (2016)
Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD
Alice Serafin et al.
NEUROLOGY (2015)
MicroRNAs as biomarker of Parkinson disease? Small but mighty
Manja Marz et al.
NEUROLOGY (2015)
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2015)
miRNA expression is highly sensitive to a drug therapy in Parkinson's disease
Anelya Kh. Alieva et al.
PARKINSONISM & RELATED DISORDERS (2015)
Disease implications of the Hippo/YAP pathway
Steven W. Plouffe et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Biobanking of CSF: International standardization to optimize biomarker development
Charlotte E. Teunissen et al.
CLINICAL BIOCHEMISTRY (2014)
MicroRNA-7 Protects against 1-Methyl-4-Phenylpyridinium-Induced Cell Death by Targeting RelA
Doo Chul Choi et al.
JOURNAL OF NEUROSCIENCE (2014)
Identification of Blood Serum Micro-RNAs Associated With Idiopathic and LRRK2 Parkinson's Disease
Teresa Botta-Orfila et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
Kasandra Burgos et al.
PLOS ONE (2014)
miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway
Apostolia Fragkouli et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls
Lucia F. Cardo et al.
JOURNAL OF NEUROLOGY (2013)
More than Cell Dust: Microparticles Isolated from Cerebrospinal Fluid of Brain Injured Patients Are Messengers Carrying mRNAs, miRNAs, and Proteins
Silke Patz et al.
JOURNAL OF NEUROTRAUMA (2013)
Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy
Gesine Respondek et al.
MOVEMENT DISORDERS (2013)
Circulating cell-free microRNA as biomarkers for screening, diagnosis, and monitoring of neurodegenerative diseases and other neurologic pathologies
Toni R. Pak et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function
Elena Minones-Moyano et al.
HUMAN MOLECULAR GENETICS (2011)
Identification of blood microRNAs associated to Parkinsonis disease
Regina Margis et al.
JOURNAL OF BIOTECHNOLOGY (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Epaminondas Doxakis
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Understanding microRNAs in neurodegeneration
Stephen M. Eacker et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Repression of α-synuclein expression and toxicity by microRNA-7
Eunsung Junn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The impact of microRNAs on protein output
Daehyun Baek et al.
NATURE (2008)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
A microRNA feedback circuit in midbrain dopamine neurons
Jongpil Kim et al.
SCIENCE (2007)
Genetics of parkinsonism
Vincenzo Bonifati
PARKINSONISM & RELATED DISORDERS (2007)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
